XML 25 R12.htm IDEA: XBRL DOCUMENT
v3.22.1

IMPAIRMENT, RESTRUCTURING AND OTHER | 6 Months Ended
--- | ---
Apr. 02, 2022
Restructuring and Related Activities [Abstract] |
IMPAIRMENT, RESTRUCTURING AND OTHER | IMPAIRMENT, RESTRUCTURING AND OTHER Activity described herein is classified within the “Cost of sales—impairment, restructuring and other” and “Impairment, restructuring and other” lines in the Condensed Consolidated Statements of Operations. The following table details impairment, restructuring and other charges (recoveries) for each of the periods presented:
| Three Months Ended |  | Six Months Ended
| April 2, 2022 |  | April 3, 2021 |  | April 2, 2022 |  | April 3, 2021
Cost of sales—impairment, restructuring and other: |  |  |  |  |  |  |
COVID-19 related costs | $ | — |  |  | $ | 12.3 |  |  | $ | — |  |  | $ | 21.0 |
Restructuring and other charges, net | 2.5 |  |  | 0.1 |  |  | 2.5 |  |  | 0.4 |
Property, plant and equipment impairments | 2.8 |  |  | — |  |  | 2.8 |  |  | — |
Operating expenses: |  |  |  |  |  |  |
COVID-19 related costs | — |  |  | 2.6 |  |  | — |  |  | 3.2 |
Restructuring and other charges (recoveries), net | 0.1 |  |  | (0.1) |  |  | 1.8 |  |  | — |
Impairment, restructuring and other charges from continuing operations | $ | 5.4 |  |  | $ | 14.9 |  |  | $ | 7.1 |  |  | $ | 24.6 |
The following table summarizes the activity related to liabilities associated with restructuring and other during the six months ended April 2, 2022:
Amounts accrued for restructuring and other at September 30, 2021 | $ | 1.9 |
Restructuring and other charges from continuing operations | 2.6 |
Payments and other | (2.7) |
Amounts accrued for restructuring and other at April 2, 2022 | $ | 1.8 |
Included in restructuring accruals, as of April 2, 2022, is $0.4 that is classified as long-term. Payments against the long-term accruals will be incurred as the employees covered by the restructuring plan retire or through the passage of time. The remaining amounts accrued will continue to be paid out over the course of the next twelve months. During the second quarter of fiscal 2022, the Company announced plans to consolidate U.S. lighting manufacturing for its Hawthorne segment into a single location and to close another recently acquired assembly facility and move those operations to its Santa Rosa, California facility. During the three and six months ended April 2, 2022, the Company’s Hawthorne segment incurred costs of $5.3 in the “Cost of sales—impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations and $0.1 in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations in connection with this restructuring initiative related to employee termination benefits and impairment of property, plant and equipment. The COVID-19 pandemic has had, and continues to have, an impact on financial markets, economic conditions, and portions of the Company’s business and industry. The Company has actively addressed the pandemic’s ongoing impact on its employees, operations, customers, consumers, and communities, by, among other things, implementing contingency plans, making operational adjustments where necessary, and providing assistance to organizations that support front-line workers. The first priority of the Company’s pandemic response has been and remains the health, safety and well-being of its employees. In addition to implementing measures to help ensure the health and safety of its employees, the Company implemented an interim premium pay allowance for certain associates in its field sales force and its manufacturing and distribution centers. Costs incurred during the three and six months ended April 2, 2022 related to COVID-19 were immaterial. During the three and six months ended April 3, 2021, the Company incurred costs of $14.9 and $24.2, respectively, associated with the COVID-19 pandemic primarily related to premium pay. The Company incurred costs of $10.7 and $19.0 in its U.S. Consumer segment, $1.5 and $1.9 in its Hawthorne segment and $0.1 in its Other segment in the “Cost of sales—impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations during the three and six months ended April 3, 2021, respectively. The Company incurred costs of $2.6 and $3.2 in its U.S. Consumer segment in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations during the three and six months ended April 3, 2021, respectively.

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets. + References No definition available. + Details
Name: | us-gaap_RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration